Submitted by Anonymous (not verified) on 30 October 2023 - 14:30
Human medicines European public assessment report (EPAR): Karvezide, irbesartan,hydrochlorothiazide, Hypertension, Date of authorisation: 16/10/1998, Revision: 47, Status: Authorised
Source: